CureMetrix and CureMatch Align to Support President Biden’s Relaunch of Cancer Moonshot

n response to President Biden’s relaunch of Cancer Moonshot and his White House commitment to end cancer as we know it, healthcare technology executives for CureMetrix and CureMatch highlighted joint innovation as core to better detection and more personalized cancer treatment.

“We commend President Biden’s program to end cancer as we know it, which starts with early detection and includes leveraging technological innovation to reduce cancer death rates by at least 50% by 2047,” said Navid Alipour, co-founder and CEO of CureMetrix and CureMatch.